SMGZY - Smiths Group plc

Other OTC - Other OTC Delayed Price. Currency in USD
19.08
+0.68 (+3.70%)
As of 1:59PM EDT. Market open.
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close18.40
Open19.22
Bid0.00 x 0
Ask0.00 x 0
Day's Range18.95 - 19.26
52 Week Range9.13 - 23.50
Volume11,800
Avg. Volume45,600
Market Cap7.566B
Beta (5Y Monthly)0.73
PE Ratio (TTM)20.90
EPS (TTM)0.91
Earnings DateN/A
Forward Dividend & Yield0.82 (4.46%)
Ex-Dividend DateOct 17, 2019
1y Target Est24.39
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Smiths Detection announces partnership with Attomarker in the development of a Triple Antibody Testing device for COVID-19
    Business Wire

    Smiths Detection announces partnership with Attomarker in the development of a Triple Antibody Testing device for COVID-19

    Smiths Detection today announces that it has partnered with Attomarker Ltd, a multiplex blood-testing technology company spun out of the University of Exeter, to help produce a robust and accurate COVID-19 antibody-testing device that could represent an evolution in rapid and precise COVID-19 antibody testing. The Medicines and Healthcare Products Regulatory Agency (MHRA) has already approved Attomarker’s Triple Antibody Test for NHS use in the UK.

  • Moody's

    Smiths Group plc -- Moody's affirms Smiths' Baa2 rating; outlook stable

    Moody's Investors Service has today affirmed the long-term issuer rating of Smiths Group plc. The outlook remains stable. The affirmation reflects Moody's expectation that the company should be in a position to maintain metrics in line with the expectation for the rating, although its divisions John Crane, Detection and Flex-Tek are likely to come under some pressure from challenges in certain end markets over the next 12 months in particular aerospace and oil & gas. Moody's also continues to note that there is some uncertainty and potential pressure on the rating from the planned Medical division demerger.

  • Smiths Detection launches iCMORE algorithms for lithium batteries and dangerous goods for HI-SCAN 10080 XCT
    Business Wire

    Smiths Detection launches iCMORE algorithms for lithium batteries and dangerous goods for HI-SCAN 10080 XCT

    Smiths Detection, a leading detection and security company, has launched iCMORE detection algorithms for lithium batteries and dangerous goods for use by its HI-SCAN 10080 XCT scanner, becoming its first explosive-detection system (EDS) to offer these options. The algorithms enhance the scanner’s detection capabilities by helping identify lithium batteries, flammable liquids and solids, and compressed and liquefied gasses, which can pose a risk should they ignite or explode.

  • Smiths Detection to Supply Security-Screening Equipment to Kuwait International Airport
    Business Wire

    Smiths Detection to Supply Security-Screening Equipment to Kuwait International Airport

    Smiths Detection, a leading threat-detection and security-technology company, will supply hold-baggage screening equipment for Kuwait’s new International Airport Terminal 2, which is currently under construction. The contract includes the installation of HI-SCAN 10080 XCT units for screening hold baggage.

  • Smiths Detection enters into agreement to acquire PathSensors to expand its biological-detection capability
    Business Wire

    Smiths Detection enters into agreement to acquire PathSensors to expand its biological-detection capability

    Smiths Detection, a global leader in detection and screening technologies, today announces that it has entered into an agreement to acquire PathSensors, a leading bio-technology solutions and environmental-testing company based in Baltimore, MD. The acquisition expands Smiths Detection’s sensing capabilities across the CBRNE (chemical, biological, radiological, nuclear and explosive) spectrum to respond quickly to emerging threats.

  • Smiths Detection Launches Ultraviolet Light Upgrade Kits for Checkpoints Capable of Killing 99.9% of Microorganisms on Baggage Trays
    Business Wire

    Smiths Detection Launches Ultraviolet Light Upgrade Kits for Checkpoints Capable of Killing 99.9% of Microorganisms on Baggage Trays

    Smiths Detection launches Ultraviolet Light Upgrade Kits for checkpoints capable of killing 99.9% of microorganisms on baggage trays

  • A Rising Share Price Has Us Looking Closely At Smiths Group plc's (LON:SMIN) P/E Ratio
    Simply Wall St.

    A Rising Share Price Has Us Looking Closely At Smiths Group plc's (LON:SMIN) P/E Ratio

    Those holding Smiths Group (LON:SMIN) shares must be pleased that the share price has rebounded 31% in the last thirty...

  • Most U.K.-Made Ventilators Won’t Arrive Ahead of Virus Peak
    Bloomberg

    Most U.K.-Made Ventilators Won’t Arrive Ahead of Virus Peak

    (Bloomberg) -- When Britain’s government issued an urgent call to industry for thousands of hospital ventilators, more than 5,000 companies offered to help. Coronavirus infections are expected to peak next week and there’s little to show for their effort.Significant deliveries from the firms are still weeks away, and the embattled National Health Service has resorted to foreign imports and loans from the armed forces and the private sector to double its ventilator count to around 10,000. While the national lockdown appears to be slowing the spread of Covid-19, the NHS may need as many as 8,000 more of the devices, according to Health Secretary Matt Hancock.​The government is under intense pressure to solve Britain’s shortage of the machines that are vital for treating critically ill patients. It already spurned an offer to join a European Union program for procuring ventilators, initially stating it was no longer a member of the bloc and could source them locally, before backtracking and saying it had missed the email inviting participation. EU leaders are struggling to coordinate a response to the virus; last night they were unable to agree on a 500 billion-euro ($543 billion) stimulus package.​It’s not that U.K. Plc can’t do the job: The machines are seen as relatively straightforward to make and much of industry has been sitting on its hands since the economy tanked. The problem is that vacuum cleaner maker Dyson Ltd., engineering contractor Babcock International Group Plc and other newcomers to the business need their designs to be fully tested and approved.It can take months for the U.K. Medicines & Healthcare Products Regulatory Agency to sign off on sensitive medical machinery. The process can be expedited, but still takes valuable time to ensure patients’ safety.“It’s a race against the clock,” said Derek Hill, a professor specializing in medical devices at University College London. The regulator is “literally working all hours making this happen fast.”For now, the supply of ventilators from British manufacturers is tiny. The NHS expects to receive 30 locally-made machines this week, compared to 300 sourced from China over the weekend.Department of Health and Social Care officials say they are confident there will be enough ventilators to meet demand, given the steps being taken to increase the number available, and as long as people continue to stay at home to reduce the spread of the virus.Pistons, TurbochargersIn the short run, the greatest hope lies with consortium Ventilator Challenge UK, which includes Meggitt Plc, Airbus SE, GKN Ltd, McLaren Automotive Ltd and Rolls-Royce Holdings Plc. They plan to churn out 1,500 ventilators a week using designs from Penlon Ltd. and Smiths Group Plc, two medical device makers that can currently only make about 50 to 60 of the machines per week on their own. The group already has an approved ventilator from Smiths. But it’s still closing in on final approval for the other, and its factories and supply chains are in need of re-calibrating, so large deliveries are unlikely before the end of April.​A breathing aid developed by engineers from the Mercedes Formula One team and University College London has been approved for use. It’s being manufactured at a rate of as many as 1,000 a day using machines that would normally produce racing car pistons and turbochargers. It’s not as sophisticated as a ventilator, but it can help reduce the need for those devices.Companies such as Babcock -- which has a government contract to make 10,000 of its Zephyr Plus ventilators -- face a longer wait for approval. They may end up being useful in a potential second or third wave of infection.Prime Minister Boris Johnson, who is in hospital with the disease, set a challenge last month to source 30,000 ventilators.The government now says fewer will be needed because lockdown measures have slowed the virus’s spread. The NHS has 2,000 extra ventilators on standby, with 1,500 more due to arrive by the end of the week, Hancock said on Sunday.(Updates with news on EU fiscal stimulus in third paragraph; adds context)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

  • Reuters

    UK's Smiths makes ventilator available to other producers

    British technology firm Smiths Group said it was making one of its ventilators available for other manufacturers to produce, part of a coordinated attempt to tackle a shortage of life-saving equipment as coronavirus spreads. The group's Smiths Medical unit was providing intellectual property and advice to other companies to make its PARAPAC Plus lightweight ventilators, and it was ramping up its own production at its site in Luton, just north of London. Smiths said it was also talking to contract manufacturers to add production capacity in the United States and elsewhere.

  • How Does Smiths Group's (LON:SMIN) P/E Compare To Its Industry, After The Share Price Drop?
    Simply Wall St.

    How Does Smiths Group's (LON:SMIN) P/E Compare To Its Industry, After The Share Price Drop?

    To the annoyance of some shareholders, Smiths Group (LON:SMIN) shares are down a considerable 49% in the last month...

  • Taking A Look At Smiths Group plc's (LON:SMIN) ROE
    Simply Wall St.

    Taking A Look At Smiths Group plc's (LON:SMIN) ROE

    Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

  • Does Smiths Group plc's (LON:SMIN) Recent Track Record Look Strong?
    Simply Wall St.

    Does Smiths Group plc's (LON:SMIN) Recent Track Record Look Strong?

    After looking at Smiths Group plc's (LSE:SMIN) latest earnings announcement (31 July 2019), I found it useful to...

  • Know This Before Buying Smiths Group plc (LON:SMIN) For Its Dividend
    Simply Wall St.

    Know This Before Buying Smiths Group plc (LON:SMIN) For Its Dividend

    Dividend paying stocks like Smiths Group plc (LON:SMIN) tend to be popular with investors, and for good reason - some...

  • SMGZY vs. SWCH: Which Stock Should Value Investors Buy Now?
    Zacks

    SMGZY vs. SWCH: Which Stock Should Value Investors Buy Now?

    SMGZY vs. SWCH: Which Stock Is the Better Value Option?

  • Despite Its High P/E Ratio, Is Smiths Group plc (LON:SMIN) Still Undervalued?
    Simply Wall St.

    Despite Its High P/E Ratio, Is Smiths Group plc (LON:SMIN) Still Undervalued?

    This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios...

  • SMGZY vs. SWCH: Which Stock Is the Better Value Option?
    Zacks

    SMGZY vs. SWCH: Which Stock Is the Better Value Option?

    SMGZY vs. SWCH: Which Stock Is the Better Value Option?

  • Moody's

    Smiths Group plc -- Moody's announces completion of a periodic review of ratings of Smiths Group plc

    Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Smiths Group plc and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.

  • Investing.com

    Premarket London: SSE Profit Rises; Wizz Air Soars

    Investing.com -- Here is a rundown of the regulatory news releases from the London Stock Exchange on Wednesday, 13th November. Please refresh for updates.

  • Smiths Group plc (LON:SMIN) Earns A Nice Return On Capital Employed
    Simply Wall St.

    Smiths Group plc (LON:SMIN) Earns A Nice Return On Capital Employed

    Today we are going to look at Smiths Group plc (LON:SMIN) to see whether it might be an attractive investment...

  • It Might Not Be A Great Idea To Buy Smiths Group plc (LON:SMIN) For Its Next Dividend
    Simply Wall St.

    It Might Not Be A Great Idea To Buy Smiths Group plc (LON:SMIN) For Its Next Dividend

    Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Smiths Group...

  • BCOR vs. SMGZY: Which Stock Is the Better Value Option?
    Zacks

    BCOR vs. SMGZY: Which Stock Is the Better Value Option?

    BCOR vs. SMGZY: Which Stock Is the Better Value Option?

  • Should Smiths Group (LON:SMIN) Be Disappointed With Their 24% Profit?
    Simply Wall St.

    Should Smiths Group (LON:SMIN) Be Disappointed With Their 24% Profit?

    Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...

  • Boasting A 14% Return On Equity, Is Smiths Group plc (LON:SMIN) A Top Quality Stock?
    Simply Wall St.

    Boasting A 14% Return On Equity, Is Smiths Group plc (LON:SMIN) A Top Quality Stock?

    One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

  • Is Smiths Group (LON:SMIN) A Risky Investment?
    Simply Wall St.

    Is Smiths Group (LON:SMIN) A Risky Investment?

    The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

  • Should You Worry About Smiths Group plc's (LON:SMIN) CEO Pay?
    Simply Wall St.

    Should You Worry About Smiths Group plc's (LON:SMIN) CEO Pay?

    Andy Smith became the CEO of Smiths Group plc (LON:SMIN) in 2015. This report will, first, examine the CEO...